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Abstract
Purpose
1) To systematically review the available scientific literature regarding specific instruments
developed and/or tested in a Spanish population, to assess these PROMs in hip arthro-
plasty; 2) to carry out a standardized assessment of their measurement properties; and 3) to
identify the best tools for use in Spain in an arthroplasty registry context.
Methods
A systematic review of PubMed/MEDLINE and EMBASE and CINHAL was done. Further-
more, a standardized assessment of the questionnaires identified using the Evaluating the
Measurement of Patient-Reported Outcomes (EMPRO) tool was performed. All develop-
ments, validation and studies aiming to assess the measurement properties of PROMs in
hip arthroplasty in the Spanish population were included. Data from the questionnaires on
metric properties was taken into account to identify the best candidates for inclusion in a
register.
Results
A total of 853 documents were found. After screening title and abstract, 13 full text docu-
ments were reviewed and 8 questionnaires adapted and validated to assess some of the
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aspects of hip arthroplasty in the Spanish population were identified. After the EMPRO
assessment, 4 questionnaires showed suitable properties (WOMAC, OAKHQOL, mini-
OAKHQOL and PFH).
Conclusions
In Spain, there are a few suitable hip-specific questionnaires currently available to assess
PROMs in hip arthroplasty surgery. Some of the more widely used questionnaires, like the
OHS and HOOS, have not been validated in the Spanish population until now. Identified
tools are suitable for use in a clinical context, however their use in an arthroplasty register is
more questionable due to the lack of validation studies of the widely used tools in other
registers.
Background
Hip arthroplasties are presently one of the most frequent elective surgeries worldwide. The evi-
dence related to these surgeries points to a significant improvement in the physical function
and health-related quality of life of the individuals, as well as the cost-effectiveness and long-
term results of these procedures [1,2].
Traditionally, studies on hip arthroplasty surgery have focused on different outcomes, com-
monly related to patient survival and type of prosthesis used for the arthroplasty [3,4]. These
studies usually aimed to assess the mortality rate of patients with a specific type of prosthesis
or the revision risk of their prosthesis. Despite this, when assessing the results of a hip arthro-
plasty, evaluating Patient-Reported Outcome Measures (PROMs) such as quality of life, pain
or physical function, among others [3,5–7] has gained importance in recent years, since they
can provide different aspects not covered by traditional outcomes like patient-centred care,
clinical decision-making or their possible implications in health policy.
There is currently a consensus, both in clinical and in research communities regarding the
importance of considering PROMs in hip arthroplasties before and after surgery [2,6,8,9]. In
the context of arthroplasty registers, this consensus is made explicit with the continuous incor-
poration and development of PROMs programs in registers around the world [10,11]. How-
ever, this consensus is not such for the most suitable tools to assess these PROMs [12]. As seen
from the conclusions of several systematic reviews, until now there have been differences
regarding the questionnaires recommended and used, in terms of the quality of different
instruments [13–17] and the tools used by arthroplasty registries and clinical trials [10,11].
The instruments used to assess PROMs in hip arthroplasties could be classified in terms of
the population they focus on. Specific tools designed to be used solely in populations with hip
pathology, e.g. Oxford hip Score (OHS), Hip disability and Osteoarthritis Outcome Score
(HOOS), or Harris Hip Score (HHS); and general tools designed for use by the population as a
whole, e.g. Short Form-12 or 36 (SF-12 or SF-36), EuroQol-5D (EQ-5D), or World Health
Organization Quality of Life Instrument (WHO-QoL) [6,13,14,18–20]. Some of these tools
have been deemed suitable measurement properties for use in hip arthroplasty populations
worldwide [10,13,14]. In spite of this evidence, and bearing in mind the differences in results
among high quality reviews, particularly with specific tools [13–15,17,21], it might be useful to
carry out a standardized assessment and systematic comparison when choosing the best tool
possible, depending on its context of use. On one hand, a standardized assessment and
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comparison could be useful to recommend a concrete tool that assesses PROMs in a clinical
context, while on the other hand, it might be useful to select the most appropriate tool to be
included in an arthroplasty register [22,23].
Focusing on hip-specific PROMs, their selection is generally context-dependent and guided
by different criteria of which could be remarkable, among others, the tradition of use in a spe-
cific context or country or the availability of a tool [11]. Despite the possible high quality of the
selected tools, these criteria are not generally based on a systematic review and comparison of
the properties of the tools. Thus, to perform systematic reviews and standardised comparisons
of these tools for specific contexts, it could be highly valuable to the decision making process
when selecting a questionnaire to assess PROMs in hip arthroplasty.
Therefore, the aims of this study are: 1) to systematically review the scientific literature
available about specific instruments developed and/or tested in a Spanish population and
Spanish language, to assess PROMs in hip arthroplasty; 2) to evaluate and carry out a standard-
ized assessment of their measurement properties; and 3) to identify the best candidates to be
used in an arthroplasty registry context in Spain.
Methods
To find relevant studies on available hip-specific tools in the Spanish population, a systematic
review was performed in accordance with Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (S1 Checklist) guidelines [24] and registered with PROSPERO under regis-
try number CRD42018083626 [25].
The search was done up to 01/01/2018 and there was no restriction on the start date.
Searches were conducted in the following databases: PubMed/MEDLINE, EMBASE and
CINAHL. They were done using a filter developed specifically for PubMed/MEDLINE, which
was then adapted for the other databases (S1 Filter). In addition, a manual search was con-
ducted to retrieve any studies that might not have been included in the review. The search
strategy and filter development was guided by previous systematic review filters used to select
PROMs tools and the Spanish population [13,14,26,27]. Furthermore, references of the
retrieved articles were screened for relevant studies, and relevant authors identified in the
developmental studies of the different tools were contacted. After the systematic review, the
tools assessed in the studies were identified and a standardized assessment of the adequacy of
their measurement properties was done using the Evaluating the Measurement of Patient-
Reported Outcomes (EMPRO) tool.
Study inclusion and exclusion criteria and the review process
Population, Intervention, Comparison, Outcome (PICO) criteria were used. All development,
adaptation, validation and studies aimed to assess the metric properties of procedure- or con-
dition-specific tools used to assess PROMs in hip arthroplasty in the Spanish population were
included. The following exclusion criteria were used: studies published in a language other
than English or Spanish, studies focused on general tools, studies not focused on patients
undergoing a hip arthroplasty or on the waiting list for one (e.g. studies focused only on osteo-
arthritis of the hip and not on hip arthroplasty), studies where it was impossible to determine
the joint operated on, surgical technique papers and case studies or studies involving fewer
than 10 patients. Due to the cross-cultural adaptation and the possible bias related to the com-
parability of metric properties between populations, only full-texts of tools developed and/or
tested in the Spanish population (from Spain) were included [28–30].
After identifying the studies, a screening was done based on the outlined inclusion/exclu-
sion criteria, first by title and abstract and then by full text. All papers that did not meet the
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inclusion criteria were excluded from the review. All documents identified were revised inde-
pendently by 2 expert reviewers (JA and JE). If the reviewers did not reach an agreement
regarding one or more papers or attributes, a third reviewer (JMV) revised the documents and
assessed the questionnaires to arrive at a consensus. After the revision, a standardized assess-
ment of metric properties of the identified tools was done by 2 reviewers (JA and EP) using the
EMPRO tool. Before the review, the comprehension of the research aims was assessed using a
10-study pilot and measured using Cohen’s Kappa statistic. None of the reviewers was
involved in developing the measures assessed.
Data extraction and standardized evaluation of proms questionnaires
Data about the instruments identified in the studies included after the screening was retrieved.
Information regarding their measurement properties was considered, following the Medical
Outcomes Trust classification [31]. In addition, a narrative synthesis of the evidence found in
each questionnaire was performed. The quality of the identified questionnaires was assessed
and compared based on the evidence found in the studies included.
For the standardized assessment of the questionnaires, the EMPRO tool was used [22].
EMPRO is a tool designed for the standardized evaluation of the quality of instruments used to
assess PROMs, based on the Medical Outcomes Trust criteria [31,32]. The questionnaire con-
sists of 39 Likert-type items with a response scale from 1 (“strongly disagree”) to 4 (“strongly
agree”) that are distributed among 8 attributes described in Table 1: Conceptual and measure-
ment model (7 items); Reliability (8 items); Validity (6 items); Responsiveness (3 items);
Interpretability (3 items); Administration burden (7 items); Alternative modes of administra-
tion (2 items); and Cross-cultural and linguistic adaptations (3 items). Additionally, the ques-
tionnaire provides a space for comments and references in each item and some items have the
response option ‘‘no information” or ‘‘not applicable” when the information is insufficient or
not suitable. To conclude the questionnaire, an overall recommendation is provided on a scale
with the following response categories: “Strongly recommended”, “Recommended with provi-
sos or alterations”, “Would not recommend” and “Unsure” with a rationale for the recommen-
dation. A score for each attribute was calculated using the mean of the responses to all items
composing that attribute and a linear transformation was done to obtain a score from 0 (the
worst possible score) to 100 (the best possible score). Finally, an overall score for the question-
naire based on the mean score of the metric-related attributes (conceptual and measurement
model, reliability, validity, responsiveness and interpretability) was obtained.
Results
Fig 1 shows a flow diagram of the review process. Using the filter developed for systematic
review, a total of 853 documents were identified. Of these, 715 (83.8%) were identified in
PubMed/MEDLINE, 91 (10.7%) in EMBASE, 41 (4.8%) in CINAHL and 6 (0.7%) through a
manual search. After checking for duplicates, 117 (13.7%) were removed. Of the remaining
736 titles, 696 were excluded, leaving a total of 40 abstracts to screen. After screening the
abstracts, 21 full text articles were considered. Of these documents, 8 were excluded: 1 was a
conference abstract, 4 were focused on hip osteoarthritis without considering hip replacement
or it was impossible to determine the operated joint, 2 aimed to establish prioritisation systems
rather than assess PROMs in hip replacement, and 1 was focused on variables that might act as
predictors of PROMs and not on their specific measurement properties. Finally, a total of 13
full text articles published between 1997 and 2017 were included in the data extraction [33–
45].
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Taking into account the instruments included in the studies (Table 2), a total of 8 tools
were identified, four of which were variants or sub-scales of other main tools. In terms of spe-
cific questionnaires, we found: The Western Ontario and McMaster Universities Osteoarthri-
tis Index (WOMAC) [33–36,44], composed by 24 Likert-type items designed to assess pain,
stiffness and physical function; two different versions of the WOMAC Short Form, each com-
posed of 11 items with 5 Likert-type items [35,37]; The WOMAC Short Form (Function
dimension) composed of 7 items validated to assess functionality in joint replacement [38];
The Pain and Function of the Hip scale (PFH) composed of 9 Likert-type items to assess pain,
Table 1. Attributes assessed using the Evaluating the Measurement of Patient-Reported Outcomes (EMPRO) tool.
Attribute Definition Items included
Conceptual and
measurement model
The rationale for and description of the concept and the populations that a measure is
intended to assess and the relationship between these concepts.
1. Concept of measurement stated
2. Obtaining and combining items described
3. Rationality for dimensionality and scales
4. Involvement of target population
5. Scale variability described and adequate
6. Level of measurement described
7. Procedures for deriving scores
Cultural adaptation Cultural and linguistic adaptation of the instrument. 8. Linguistic equivalence
9. Conceptual equivalence
10 Differences between the original and the
adapted versions
Reliability The degree to which an instrument is free from random error. Internal consistency:
11. Data collection methods described
12. Cronbach’s alpha adequate
13. IRT estimates provided
14. Testing in different populations
Reproducibility:
15. Data collection methods described
16. Test–retest and time interval adequate
17. Reproducibility coefficients adequate
18. IRT estimates provided
Validity The degree to which the instrument measures what it purports to measure. 19. Content validity adequate
20. Construct/criterion validity
adequate
21. Sample composition described
22. Prior hypothesis stated
23. Rational for criterion validity
24. Tested in different populations
Responsiveness An instrument’s ability to detect change over time. 25. Adequacy of methods
26. Description of estimated magnitude of
change
27. Comparison of stable and unstable groups
Interpretability The degree to which one can assign easily understood meaning to an instrument’s
quantitative scores.
28. Rational of external criteria
29. Description of interpretation strategies
30. How data should be reported stated
Burden The time, effort, and other demands placed on those to whom the instrument is
administered (respondent burden) or on those who administer the instrument
(administrative burden).
Respondent:
31. Skills and time needed
32. Impact on respondents
33. Not suitable circumstances
Administrative:
34. Resources required
35. Time required
36. Training and expertise needed
37. Burden of score calculation
Alternative modes of
administration
Alternative modes of administration used for the administration of the instrument 38. The metric characteristics and use of each
alternative mode of administration
39. Comparability of alternative modes of
administration
https://doi.org/10.1371/journal.pone.0214746.t001
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function and mobility/strength [41,42,45]; The Osteoarthritis Knee and Hip Quality of Life
(OAKHQOL) composed of 43 Likert-type items, 40 of which are used to assess physical activ-
ity, mental health, pain, social support and social functioning [39]; The Mini-OAKHQOL
composed of 20 Likert-type items to assess the same dimensions as the long version (OAKH-
QOL); and the Harris Hip Score (HHS), with 10 Likert-type items that assess pain, function,
amplitude of movement and absence of deformity [43].
Considering the properties of the identified tools, Table 3 shows their adaptation according
to the EMPRO standardized assessment. Based on the overall score, it was observed that only
OAKHQOL, mini-OAKHQOL, WOMAC and PFH could be considered as reasonably accept-
able (EMPRO overall score > = 50). The highest overall score corresponded to WOMAC with
a score of 65.47, followed by OAKHQOL with a score of 58.87, mini-OAKHQOL with 58.57
points and PFH with 50.71 points. In addition, focusing on the specific metric attributes it was
observed that all the assessed tools have EMPRO scores equal to or higher than 50 in reliability,
Fig 1. Review process. Flow diagram.
https://doi.org/10.1371/journal.pone.0214746.g001
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validity and responsiveness, except PFH in validity. Only WOMAC and PFH had a score equal
to or higher than 50 points in conceptual and measurement model and in interpretability.
Regarding non-metric attributes (cultural adaptation and burden), only OAKHQOL had a
score equal to or higher than 50 points.
Discussion
Nowadays in Spain, the availability of specific tools to assess PROMs in hip arthroplasty is lim-
ited. After the systematic review of the available literature, only eight instruments (including
short forms) were identified. Of these instruments only WOMAC, OAKHQOL, mini-OAKH-
QOL, and PFH, have shown suitable measurement properties to be used in the Spanish popu-
lation. In addition, none of the most widely used hip-specific questionnaires was identified in
arthroplasty registers around the world [10,11,21]. This evidence suggests that there are some
Table 2. General characteristics of the instruments identified from validation studies in hip arthroplasty population.
Questionnaire Author (year) Number of items and type Assessed dimensions (number of items) Punctuation
Western Ontario and
McMaster Universities
Osteoarthritis Index
(WOMAC)
Escobar et al.
(2002)
Quintana et al.
(2005)
Lopez Alonso
et al. (2009)
Escobar et al.
(2012)
Quintana et al
(2012)
24 Likert-type items with a
5-point response scale
Pain (5 items), stiffness (2 items) and physical
function (17 items)
Standardized from 0 (best
health status) to 100 (worst
health status)
WOMAC Short Form (v1) Bilbao et al.
(2011)
11 Likert-type items with a
5-point response scale
Pain (3 items) and physical function (8 items) Standardized from 0 (best
health status) to 100 (worst
health status)
WOMAC Short Form (v2) Lopez Alonso
et al. (2009)
11 Likert-type items with a
5-point response scale
Symptomatology and physical disability in: repose
(4 items), movement on stairs (3 items), put on or
take off shocks (2 items), and Stiffness (2)
NS
WOMAC (Short Form.
Function dimension)
Escobar et al.
(2011)
7 Likert-type items with a
5-point response scale
Functional capacity (capacity to do activities) Standardized from 0 (best
health status) to 100 (worst
health status)
Osteoarthritis Knee and Hip
Quality of Life (OAKHQOL)
Gonzalez Saenz
de Tejada et al.
(2011)
43 Likert-type items with a
10-point response scale
Physical activity (16 items), mental health (13
items), pain (4 items), social support (4 items), and
social functioning (3 items) and three independent
items addressing sex life, professional life and fear of
being dependent
Standardized from 0 (worst
quality of life) to 100 (best
quality of life)
Mini-OAKHQOL Gonzalez Saenz
de Tejada et al.
(2017)
20 Likert-type items with a
10-point response scale
Physical activity (7 items), mental health (3 items),
pain (3 items), social support (2 items), and social
functioning (2 items) and three independent items
addressing sex life, professional life and fear of being
dependent
Standardized from 0 (worst
quality of life) to 100 (best
quality of life)
Pain and Function of the Hip
scale (PFH)
Valls et al.
(1997)
Alonso et al.
(2000)
Marti-Valls
et al. (2000)
9 Likert-type items with
different point response scales
depending on the specific
dimension.
Pain (2 items), function (3 items) and mobility/
Strength (4 items)
From 0 (total functional
limitation) to 85 (absence of
functional limitation)
Harris Hip Score (HHS) Navarro
Collado et al.
(2005)
10 Likert-type items (different
points for each response
scale)
Pain (1 item), function (7 items), amplitude of
movement (1 item) and absence of deformity (2
items)
From 0 (worst possible
functional capacity) to 100
(best possible functional
capacity)
v1: version 1; v2: version 2; NS: Not explicitly specified
https://doi.org/10.1371/journal.pone.0214746.t002
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suitable tools to be included in an arthroplasty register currently in Spain but, before deciding
to do so, it might be valuable to carry out validation studies of widely used hip-specific tools in
other registers worldwide as OHS and HOOS.
Taking into account the specific tools assessed in our study, only 4 were identified as suit-
able candidates and 1 of them, mini-OAKHQOL, was a shorter version of one of the main
tools. Of these tools, the most acceptable, according to EMPRO guidelines, was WOMAC,
which was the only tool used by 4 other arthroplasty registers worldwide [11]. In addition, the
similarity between the EMPRO overall scores from OAKHQOL and the shorter version should
be highlighted. Given the similarity in metric properties, we could argue that it would be better
to use the mini-OAKHQOL tool over the full version since it has a lower burden, but this
hypothesis requires more evidence to support it.
Several reviews assessing the acceptability of instruments to evaluate PROMs in hip arthro-
plasty were previously done in other countries [13–15,17]. From these reviews, specific instru-
ments used with better properties were identified, which in most cases were the OHS and the
HOOS. In addition, the most common instruments used in other registries were also the OHS
and HOOS [10,21].
Regarding OHS, this questionnaire is one of the most widely used for different reasons,
among which could be highlighted its length, including only 12 items, and its acceptable met-
ric properties to be used in a wide range of languages and countries. Despite this, for the Span-
ish population, only one validation study was found [46]. This study was condition-focused
and not procedure-focused, which was why we decided to exclude it. Patient characteristics of
the population included in this study might be different from arthroplasty patients. For this
reason, and bearing in mind one of the objectives was to select the best candidate tool to be
included in an arthroplasty register, we decided to discard this study, again showing the need
for procedure-focused validation studies of this questionnaire. The HOOS questionnaire is
also one of the most widely used questionnaires in hip arthroplasties, used by the Swedish
Arthroplasty Register among others [47], and has shown its acceptability in metric terms in
other contexts [13,14,18,20,48]. With these reasons in mind, we propose that the adaptation
and validation of OHS and HOOS in the hip arthroplasty population could be valuable in our
Table 3. Attributes of each of the questionnaires identified from the studies included in the systematic review. EMPRO.
Questionnaire Conceptual and
measurement model
Cultural
adaptation
Reliability Validity Responsiveness Interpretability Burden Alternative modes of
administration
Overall
score
WOMAC ++ + ++ ++ +++ ++ + + 65.47
WOMAC SF
(v1)
+ + ++ ++ ++ + + - 48.99
WOMAC SF
(v2)
+ + ++ + + + + - -
WOMAC SF
(FD)
+ + ++ + +++ + + - -
OAKHQOL + +++ ++ ++ +++ + ++ - 58.87
Mini-
OAKHQOL
+ + +++ ++ +++ + + - 58.57
PFH ++ + ++ + ++ ++ + - 50.71
HHS + + + + ++ + + - -
WOMAC: Western Ontario and McMaster Universities Osteoarthritis Index; SF: Short form; v1: version 1; v2: version 2; FD: Function dimension; OAKHQOL:
Osteoarthritis Knee and Hip Quality of Life; PFH: Pain and Function of the Hip Scale; HHS: Harris Hip Score
+: EMPRO score 25–49; ++: EMPRO score 50–74; +++: EMPRO score 75–100; -: EMPRO score not applicable or not calculable
https://doi.org/10.1371/journal.pone.0214746.t003
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context, both for clinical use and to know what could be the most acceptable tool for inclusion
in an arthroplasty register.
Finally, and despite the suitability of the metric properties of all tools in which was possible
to calculate an EMPRO overall score, except WOMAC Short Form whose score was on the
border of acceptability, we should highlight that they might only be considered as partially
suitable candidates for inclusion in an arthroplasty register. As these tools are not among those
most used by other registries, it is difficult to pool data and compare them. Additionally, when
the properties of PROMs tools were compared in other contexts and countries [13,14,17],
these tools were not present in some cases, OAKHQOL mini-OAKQOL and PFH, for exam-
ple, or they were not the best candidates for adequacy or specificity. On the other hand, focus-
ing on WOMAC, it should also be noted that the full questionnaire is included in HOOS,
which is one of the more widely used questionnaires to assess PROMS in hip arthroplasties
[14,20,48,49].
Some limitations of this review should be discussed. Firstly, we should mention that we
only examined tools developed and/or tested in the population from Spain. This inclusion cri-
teria, seems to limit the scope of the study. In spite of this, we think that with this approach,
our results are much more accurate. Thus, we deem that they could be much more useful for
the clinical community of Spain and, furthermore, they may serve as baseline for future com-
parative studies between countries. Besides, we have to remark the possible publication bias
that could affect the results shown. Studies about PROMs could be unpublished or published
as grey literature. Despite this, we have tried to be as exhaustive as possible in the literature
search and have also tried to contact the most influential authors. As such, we feel that we have
identified at least the main validation literature focused on hip arthroplasty specific tools.
Another limitation is that we have excluded studies focused on patients with OA if the patients
included in the studies were not on a waiting list or undergoing hip arthroplasty. Though OA
is by far the most common cause of total hip replacement, it should be noted that not all
patients affected by OA are eligible candidates for an arthroplasty [50–53]. OA is a chronic
condition that could affect people with very different characteristics, including young patients
and patients with non-severe OA. Young patients able to perform their daily activities well
should not be eligible for an arthroplasty, and especially not for a total hip replacement. For
these reasons, we consider the outlined inclusion and exclusion criteria appropriate to address
the aims of this study. In addition, we want to point out the limitation related to including
only hip specific tools and not general tools. General instruments are widely studied and
should be used as the first approach to PROMs assessment. Nevertheless, and despite their use
for assessment of specific populations, these instruments were not specifically designed to
assess PROMs, which means their responsiveness could be compromised. Furthermore, in
some cases the constructs evaluated with general tools are not the same or not entirely equiva-
lent than those evaluated by the specific tools. After taking the conceptual differences between
general and specific tools into account, particularly when used in specific populations, we
decided to exclude general tools. Finally, we should highlight the lack of validation studies
developed from the Item Response Theory (IRT) perspective. Including this approach when
evaluating the metric properties of questionnaires could improve the precision of their assess-
ment and decision making when selecting a specific tool.
In conclusion, our study shows that currently in Spain, there are some specific question-
naires with adequate metric properties to assess PROMs in hip arthroplasty. These tools are:
WOMAC, OAKHQOL, mini-OAKHQOL and PFH. While these tools might be considered
suitable for use in a clinical context, their recommendation for use in an arthroplasty register
is more questionable, mainly due to the lack of validation studies of the OHS and HOOS, the
more widely used tools in this context.
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